Federico Garrido

Overview

Best Publications

• IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS

  Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar

  1026
  Citations

• MHC class I antigens, immune surveillance, and tumor immune escape.

  Angel Garcia-Lora;Ignacio Algarra;Federico Garrido

  667
  Citations

• The urgent need to recover MHC class I in cancers for effective immunotherapy

  Federico Garrido;Natalia Aptsiauri;Elien M Doorduijn;Angel M Garcia Lora

  626
  Citations

• Natural history of HLA expression during tumour development

  Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew

  610
  Citations

• MHC antigens and tumor escape from immune surveillance.

  Federico Garrido;Ignacio Algarra

  394
  Citations

• The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

  Ignacio Algarra;Angel García-Lora;Teresa Cabrera;Francisco Ruiz-Cabello

  386
  Citations

• "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

  Federico Garrido;Teresa Cabrera;Natalia Aptsiauri

  344
  Citations

• Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

  Sylvie Rusakiewicz;Michaela Semeraro;Matthieu Sarabi;Mélanie Desbois

  334
  Citations

• HLA class I antigen abnormalities and immune escape by malignant cells.

  Barbara Seliger;Teresa Cabrera;Federico Garrido;Soldano Ferrone

  326
  Citations

• Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.

  Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez

  308
  Citations

• A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

  Eva Jiménez-Medina;Angel Garcia-Lora;Laura Paco;Ignacio Algarra

  284
  Citations

• Analysis of HLA-E expression in human tumors

  Rosario Marín;Francisco Ruiz-Cabello;Susana Pedrinaci;Rosa Méndez

  238
  Citations

• The HLA crossroad in tumor immunology.

  Ignacio Algarra;Teresa Cabrera;Federico Garrido

  235
  Citations

• Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

  C M Cabrera;P Jiménez;T Cabrera;C Esparza

  221
  Citations

• High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

  T. Cabrera;A. Collado;M.A. Fernandez;A. Ferron

  221
  Citations

• Further evidence for derepression of h-2 and ia-like specificities of foreign haplotypes in mouse tumour cell lines.

  Federico Garrido;Hilliard Festenstein;Volker Schirrmacher

  200
  Citations

• Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

  R Benitez;Danièle Godelaine;M A Lopez-Nevot;F Brasseur

  194
  Citations

• HLA class I antigens in human tumors.

  Federico Garrido;Teresa Cabrera;Miguel Angel Lopez-Nevot;Francisco Ruiz-Cabello

  190
  Citations

• Role of Altered Expression of HLA Class I Molecules in Cancer Progression

  Natalia Aptsiauri;Teresa Cabrera;Rosa Mendez;Angel Garcia-Lor

  181
  Citations

• Rejection versus escape: the tumor MHC dilemma

  Federico Garrido;Francisco Ruiz-Cabello;Natalia Aptsiauri

  178
  Citations

• MHC Class I Antigens and Immune Surveillance in Transformed Cells

  Natalia Aptsiauri;Teresa Cabrera;Angel Garcia-Lora;Miguel Angel Lopez-Nevot

  175
  Citations